image: Johnson V. John, Ph.D., Assistant Professor and head of the Functional Biomaterials Laboratory at the Terasaki Institute for Biomedical Innovation, has been appointed a standing member of the NIH Musculoskeletal Tissue Engineering Study Section.
Credit: Terasaki Institute for Biomedical Innovation
Los Angeles, CA – November 7, 2025 - The Terasaki Institute proudly announces that Johnson V. John, Ph.D., Assistant Professor at the Institute, has been appointed as a standing member of the Musculoskeletal Tissue Engineering (MTE) Study Section within the Center for Scientific Review at the National Institutes of Health (NIH). His four-year term is scheduled to begin in November 2025.
The MTE Study Section plays a central role in the NIH’s rigorous peer-review process, evaluating competitive research proposals focused on biomaterials, cellular and molecular strategies, and engineering approaches that drive advances in musculoskeletal tissue repair and regeneration.
Appointment as a standing member is one of the most prestigious forms of scientific service at the NIH. Members are chosen through a highly selective national process based on their research accomplishments, publication record, and recognized leadership in their field. Standing members provide continuity, expertise, and mentorship throughout the review process and help shape national research priorities in biomedical innovation.
At TIBI, Dr. John leads the Functional Biomaterials Laboratory, where his team develops nanofiber and microgel-based biomaterials for applications including wound healing, bone regeneration, and muscle repair. He currently serves as Principal Investigator on numerous grants including an NIH R01 grant focused on diabetic wound healing and other multiple multi-institutional NIH-funded projects in regenerative medicine and tissue engineering.
“This appointment is both an honor and a responsibility,” said Dr. Johnson V. John. “Serving on the MTE Study Section allows me to contribute to the NIH’s mission by ensuring that innovative and impactful research receives the support it deserves. It’s also a valuable opportunity to engage with the broader scientific community driving advancements in musculoskeletal tissue engineering.”
Stewart Han, President of the Terasaki Institute, praised the appointment: “Dr. John’s selection to the NIH study section is a testament to his scientific excellence and the impact of his research. It reflects the Terasaki Institute’s commitment to empowering visionary scientists whose work translates directly to improving human health.”
For more information, please contact:
Dr. Johnson V. John Assistant Professor, Functional Biomaterials Laboratory
Terasaki Institute for Biomedical Innovation
Email: jjohnson@terasaki.org
About the Terasaki Institute for Biomedical Innovation
The Terasaki Institute for Biomedical Innovation is a non-profit research organization that invents and fosters practical solutions that restore or enhance the health of individuals. The Institute aims to enhance the quality of human life through translational research and the acceleration of biomedical innovation. TIBI's research focuses on the development of biomaterials, cellular and tissue engineering, medical devices, and microfluidic systems.
###